×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Senator claims GSK pulled popular asthma med to dodge inhaler price caps
Fierce Pharma
It's been a turbulent few days for GSK's respiratory business: On Tuesday, the U.S..
22 hours ago
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Yahoo Finance
Deciphera Pharmaceuticals, Inc. (DCPH) and GSK are in focus on acquisition news and Q1 earnings, respectively.
1 day ago
Senator slams GlaxoSmithKline over pricey inhaler for children
The Washington Post
Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs, Sen. Maggie Hassan (D-N.H.) is accusing the company of...
2 days ago
GSK raises profit outlook on strong vaccine, HIV drug sales
Reuters
GSK raised its full-year profit forecast on Wednesday on strong demand for its common respiratory vaccine and specialty HIV medicines,...
3 days ago
GSK pushes back on FTC 'junk patents' claim as it raises profit outlook
Financial Times
GSK has pushed back on US claims it is holding back competition among drugmakers with “junk patents”, after the country's Federal Trade...
3 days ago
GSK Non-GAAP EPS of 43.10p, revenue of £7.4B; updates FY24 outlook (NYSE:GSK)
Seeking Alpha
Mohamad Faizal Bin Ramli. GSK press release (NYSE:GSK): Q1 Non-GAAP EPS was 43.10p. Revenue was £7.4B (+6.5% Y/Y), +10% CER and +13% ex...
3 days ago
FTC Targets ‘Junk’ Patents Including Novo’s Ozempic, GSK’s Trelegy Ellipta and Other Drugs
BioSpace
In a bid to improve competition in the industry, the U.S. Federal Trade Commission is challenging the patents of 20 different pharmaceutical...
3 days ago
GSK (GSK) Q1 Earnings and Revenues Surpass Estimates
Yahoo Finance
Glaxo (GSK) delivered earnings and revenue surprises of 15.96% and 3.99%, respectively, for the quarter ended March 2024.
3 days ago
GSK knew about Zantac cancer risk, attorneys tell jury in first trial
Reuters
U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in...
1 day ago
GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook
Yahoo Finance
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% excluding...
2 days ago